about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNatural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.Regulation of human NK-cell cytokine and chemokine production by target cell recognition.Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.New approaches in the immunotherapy of haematological malignancies.Natural killer cell-triggering receptors in patients with acute leukaemia.Increased NK Cell Maturation in Patients with Acute Myeloid LeukemiaKinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells.Activating killer cell Ig-like receptors in health and disease.Molecular mechanisms of natural killer cell activation.Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor ActivityAdenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression.Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell educationAML drug resistance: c-Myc comes into playB-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodiesEducation of human natural killer cells by activating killer cell immunoglobulin-like receptorsImpaired activating receptor expression pattern in natural killer cells from patients with multiple myelomaDefective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients
P50
Q26751011-0B67D436-7856-477E-A031-3EC82AFEFD60Q33734571-39AA0E8B-7B47-497C-BD30-C4677D7ACEFDQ33747309-CA446CF6-8578-4595-A99A-A6EBB4347EA4Q34501427-399CCE05-8D2F-4A27-BCC9-FA2834171A2AQ35106657-64028B81-8E8B-4F9B-8FE6-5E2187DD0CF3Q35614641-F026727D-FC38-4226-A599-03EA143C83F9Q36256263-2D8444F9-9266-4F73-9F25-6A2D7F969736Q37620061-52416262-033B-412F-887C-9FF336E71F53Q37725657-0AA11516-2190-4D53-ACD5-2FDFFADA09D8Q37860083-48316AEC-55EE-4092-A80C-F88133415BAEQ38203261-9A56BCFE-D055-48AB-8610-A3B4823ECEA5Q38861743-E6342574-7503-4239-A6B5-215B0191C280Q41472587-F3ED7341-2B5C-4C3B-8B09-A63D3D210E41Q41550194-56E49E26-7B82-44A5-AAF6-701C4413B750Q44023209-8CF5E4BF-A8E5-4854-A40D-CAA42364601FQ45009828-7B158F36-4E03-4DE5-817F-726285CA35FBQ45950820-49699424-6578-46B0-BEA9-D2D78796AC7DQ51755826-665B5154-B0A8-4E6B-BDDF-F8E554CDF5E8Q53342536-B5014631-5076-4B43-9B51-77DED25AE5C8Q56875357-A65698FE-E8E3-4845-A2D5-4D92F74208EDQ61905845-5D3A8847-C2F1-4829-B336-054C364C88AEQ61905852-1E697C04-31EF-41AB-9292-24DC4AF1802AQ61905881-4EB68AB3-671D-4E89-8A9B-F709566AB9BDQ61905908-A2C3BD09-254C-4B5F-ABAD-0E95A1922C32Q61905914-63639681-2ED5-47AB-AFED-75231F6E7956
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cyril Fauriat
@ast
Cyril Fauriat
@en
Cyril Fauriat
@es
Cyril Fauriat
@nl
Cyril Fauriat
@sl
type
label
Cyril Fauriat
@ast
Cyril Fauriat
@en
Cyril Fauriat
@es
Cyril Fauriat
@nl
Cyril Fauriat
@sl
prefLabel
Cyril Fauriat
@ast
Cyril Fauriat
@en
Cyril Fauriat
@es
Cyril Fauriat
@nl
Cyril Fauriat
@sl
P106
P21
P31
P496
0000-0002-4850-6831